With a grant from the ACR’s Rheumatology Research Foundation, Nancy J. Olsen, MD, hopes to discover how methotrexate interacts with immune system cells and ultimately helps to control the system’s attack on joints
ACR/ARHP Annual Meeting 2012: Fatigue for People with Rheumatoid Arthritis Rooted in Physiological and Psychological Factors
Researchers find that genes, gender, and cognition all contribute to fatigue in rheumatoid arthritis (RA)
The ARHP Honors Health Professionals for their Contributions to Rheumatology
The ARHP recognized individuals for their work in advancing rheumatology research, education, and patient care at the organizations’ annual meeting in Washington, D.C. last November
With a Five-Point Plan and New Name, the Rheumatology Research Foundation Continues to Advance the Field of Rheumatology
Supporting research and education in rheumatology is the core mission of the American College of Rheumatology’s (ACR) Rheumatology Research Foundation
A Rheumatology Research Foundation-funded Physician Studies the Overall Impact of Osteoarthritis
Amanda E. Nelson, MD, MSCR, is using a grant from the Rheumatology Research Foundation to create a way to measure of the overall burden of osteoarthritis throughout the whole body
ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus
Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis
A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.
Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients
In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.
Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis
A grant from the American College of Rheumatology (ACR)’s Rheumatology Research Foundation has helped Shiva Shahrara, PhD, conduct research into the molecule, IL-17, that plays a role in recruiting myeloid cells to migrate from the blood to the joint and perpetuating vascularization
- « Previous Page
- 1
- …
- 86
- 87
- 88
- 89
- 90
- …
- 123
- Next Page »